Quantcast
Last updated on April 17, 2014 at 9:32 EDT

Latest prostate cancer treatment Stories

2011-09-10 11:06:00

NEW YORK, Sept. 10, 2011 /PRNewswire/ -- September marks Prostate Cancer Awareness Month, and as a result, women throughout the United States have a valuable addition to the infamous honey-do list. As the second leading cause of death in U.S. men, prostate cancer will affect close to 218,000 this year, many with almost no symptoms. Sadly, 32,000 of those men will succumb to the disease. What Dr. David Samadi, Vice Chairman, Department of Urology, and Chief of Robotics and Minimally...

2011-08-17 18:01:00

NEW YORK, Aug. 17, 2011 /PRNewswire/ -- Dr. David Samadi, Vice Chairman, Department of Urology, and Chief of Robotics and Minimally Invasive Surgery at The Mount Sinai Medical Center knows the wide range of emotions and fears that men with prostate cancer face. As a robotic prostatectomy and prostate cancer treatment expert, Dr. Samadi cares for the total patient, helping them deal with all aspects of treatment, recovery and cure. Robotic prostatectomy procedures, performed to remove the...

2011-08-13 00:00:29

Prostate Cancer Treatment Specialist Stephen J. M. Banks, M.D., Has Joined the Martin-O'Neil Cancer Center Team at St. Helena Hospital. St. Helena, CA (PRWEB) August 12, 2011 St. Helena Hospital's Martin-O'Neil Cancer Center (MOCC) welcomes Dr. Stephen J. M. Banks, M.D. as a member of its Radiation Oncology team. Nationally recognized for his clinical expertise and his contributions to advances in the field of radiation oncology, Dr. Banks specializes in the treatment of prostate cancer...

2011-08-03 15:30:00

NEW YORK, Aug. 3, 2011 /PRNewswire/ -- Dr. David Samadi, Vice Chairman, Department of Urology, and Chief of Robotics and Minimally Invasive Surgery at The Mount Sinai Medical Center, welcomed 130 academically outstanding high school students to witness a live robotic prostatectomy procedure. National Youth Leadership Forum on Medicine (NYLF/MED) invited Dr. Samadi to be part of their ten-day residential program for exceptional high school students in the greater tri-state area. As a...

2011-06-23 15:30:00

NEW YORK, June 23, 2011 /PRNewswire/ -- For years, researchers have dreamed of curing prostate cancer with targeted drugs that could modulate the body's own immune system to attack and destroy malignant cancer cells. Recent approvals of immuno-modulatory drugs Provenge and Yervoy represent considerable progress in this domain, as they have already been shown to improve survival rates in certain types of metastatic prostate cancer. Over 20 other such drugs are expected to seek approval in...

2011-05-26 14:18:00

NEW YORK, May 26, 2011 /PRNewswire/ -- A new prostate cancer study published in the New England Journal of Medicine comparing surgical treatment to "watchful waiting" revealed important findings for patients newly diagnosed with prostate cancer and currently debating their treatment options. (Photo: http://photos.prnewswire.com/prnh/20110526/NY09899 ) Two of the most commonly offered clinical options for early prostate cancer treatment today are "watchful waiting" and radical...

2011-05-09 15:09:00

NEW YORK, May 9, 2011 /PRNewswire/ -- Robotic prostatectomy and prostate cancer treatment expert Dr. David Samadi, Vice Chairman, Department of Urology, and Chief of Robotics and Minimally Invasive Surgery at The Mount Sinai Medical Center in New York City, says a return to a normal sex life can be achieved after robotic prostate surgery. Thanks to the nerve-sparing feature of his signature surgical technique, a majority of men (85%) recover their potency within one year of the procedure....

2011-04-19 14:45:00

NEW YORK, April 19, 2011 /PRNewswire/ -- According to a research from Northwestern Medicine, a new PSA (prostate-specific antigen) screening test for prostate cancer can more accurately identify aggressive forms of the disease and substantially reduce false positives, as compared to the two methods currently available. "This discovery is especially significant for men over 50 whose PSA levels put them in a 'gray zone,' where a biopsy may not be needed," said Dr. David B. Samadi, a prostate...

2011-03-10 12:49:00

NEW YORK, March 10, 2011 /PRNewswire/ -- Last Saturday, Kenyan Minister of Medical Services Peter Anyang Nyong'o stepped off a plane and onto Kenyan soil to a hero's welcome. His return marked the end of a nearly year long struggle with prostate cancer. Having been met with the harsh realities of the state of cancer treatment in his own country after he was diagnosed in June of last year, Nyong'o, like many others, turned his search for a prostate cancer remedy to the United States, a...

2010-12-29 10:44:00

NEW YORK, Dec. 29, 2010 /PRNewswire/ -- Dr. David Samadi, the Vice Chairman, Department of Urology, and Chief of Robotics and Minimally Invasive Surgery at The Mount Sinai Medical Center in New York City, wrapped up his groundbreaking trip to Israel with the completion of six successful robotic prostate cancer treatment surgeries. Via these prostate cancer surgeries, three of which were televised live, Samadi demonstrated his SMART technique (Samadi Modified Advanced Robotic Technique) to...